NCT07654504 Validity and Reliability of the Turkish Version of the Impact of Brachial Plexus Injury Questionnaire (IMBPIQ)
| NCT ID | NCT07654504 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Biruni University |
| Condition | Brachial Plexus Birth Palsy |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2026-08-01 |
| Primary Completion | 2026-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2026-08-01 with a primary completion date of 2026-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this methodological study is to translate the Impact of Brachial Plexus Injury Questionnaire (IMBPIQ) into Turkish, culturally adapt it, and evaluate its validity and reliability for use in adults with brachial plexus birth palsy. The study will include 50 adult participants aged 18 years and older with a diagnosis of brachial plexus birth palsy. Participants will complete the Turkish version of the IMBPIQ, as well as the Disabilities of the Arm, Shoulder and Hand questionnaire and the Short Form-36. The psychometric properties of the Turkish IMBPIQ will be examined using reliability and validity analyses, including internal consistency, test-retest reliability, and construct validity.
Eligibility Criteria
Inclusion Criteria: * Being 18 years of age or older. * Having a diagnosis of brachial plexus birth palsy. * Having the ability to read, write, speak, and understand Turkish. * Agreeing to participate voluntarily in the study and signing the informed consent form. Exclusion Criteria: * Having a neurological disease. * Having another orthopedic problem or a history of trauma in the affected upper extremity. * Having a severe cognitive or communication impairment that may prevent completion of the questionnaires or understanding of the study instructions. * Having a history of systemic disease requiring an acute attack or hospitalization within the last three months. * Being pregnant or being in the postpartum period of less than 6 months.
Contact & Investigator
Zeynep Hosbay, Physiotherapist, Prof.
STUDY DIRECTOR
Biruni University
Frequently Asked Questions
Who can join the NCT07654504 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Brachial Plexus Birth Palsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07654504 currently recruiting?
Yes, NCT07654504 is actively recruiting participants. Contact the research team at fahrib@biruni.edu.tr for enrollment information.
Where is the NCT07654504 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07654504 clinical trial?
NCT07654504 is sponsored by Biruni University. The principal investigator is Zeynep Hosbay, Physiotherapist, Prof. at Biruni University. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.